The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com
27 Mar 2023
DUBLIN--(BUSINESS WIRE)--The "The Market and Future Potential for Molecular Point of Care (mPOC), 2023" report has been added to ResearchAndMarkets.com's offering.
'The Market and Future Potential for Molecular Point of Care (mPOC), 2023'
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from a novel trend to a significant contributor to the market.
The instruments sold by Abbott, BioMerieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point-of-care testing and microbiology IVD.
The report provides market sizing, forecasting, trend mapping and competitive analysis for point-of-care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings.
The data in The Market and Future Potential for Molecular Point of Care (POC), 2023 includes information on systems and competitor analysis, as well as data on the size and growth of the market:
What are the mPOC market opportunities beyond COVID-19?
What are the current systems on the market? Who's winning?
What's the size of the Molecular Point of Care Market: 2022-2027
Geographic Breakout of the Molecular Point of Care Market, 2021 (N. America, Europe, APAC, RoW)
Segment Breakout of Molecular Point of Care Market, 2022 (Respiratory vs. Other)
Respiratory Segment Breakout, 2022 (Flu, RSV, Strep, Other)
Breakout of mPOC Respiratory, 2022 (%; Flu, Strep, RSV, Other)
Near Patient Molecular IVD Market: 2022-2027
Near Patient Molecular Market Share by Vendor, 2022
Molecular Point of Care Market Share by Vendor, 2022
Company Profiles
Companies covered in this report, in profiles and/or product tables and market developments discussion include:
Aidian Oy
binx health, inc.
Credo Bioscience
Cue Health
Curiosity Diagnostics (Bio-Rad)
Fluxergy
MicroGEM
Nanopath
Rover Diagnostics
Key Topics Covered
Chapter 1: Executive Summary
Molecular Point of Care Market, 2022-2026 ($M)
Near Patient Molecular Systems Market: 2022-2027 ($M)
Where is Molecular Point of Care in 2023?
Molecular Point of Care Market, 2022-2027 ($M)
Molecular Point of Care Market Analysis
Molecular Point of Care Market, 2022-2027 (%)
Mpoc Market by Disease Indication, 2022 (%; Respiratory, Other)
Market Observations
"Near-Patient" Molecular Systems Market
Mpoc and Near-Patient Market, 2022-2027
Near Patient Molecular Systems Market, 2022-2027 ($M and %)
Current Trends
Molecular Point-Of-Care Diagnostics Defined
Usage of Molecular Point of Care
Leading Mpoc Platforms
Molecular Poc Diagnostic Platforms and Technologies
Trends
Scope and Methodology
Chapter 2: Molecular Point-Of-Care Market Development and Trends
Covid-19 and Molecular Poc
Molecular Poc Covid-19 Emergency Authorizations
Cdc Initial Response, Long Term Situation
Covid-19's Unique Challenge
Barda Directs Funding to Mpoc
Recent Regulatory Developments
Consortia, Funding, Prizes
Deals
Deals in Molecular Point of Care, April 2019-January 2023
Advantages and Disadvantages of Molecular Point of Care
Disadvantages of Molecular Point of Care, by Setting (Physician Office Laboratory (Pol) / Other Outpatient Settings, Developing and Low-Resource Areas, and Hospital Poc)
Justification: the Sensitivity/Specificity Argument
New Systems and Menu Expansion
Mesa Biotech Strep a Approval
Combination Tests Enter Market: Sars-Cov-2, Flu A, Flu B, and Rsv
Sti Continues to Be a Growth Area
Deals, Investment in Mpoc Systems
Thermo Acquires Mesa Biotech
Eu Researchers Awarded €3M to Develop Poc Molecular Tests
Scope Fluidics Ast System Sees Investment
China as a Poc Market
Common Tests and Analytes in Poc Diagnostics
Component Technologies of Molecular Point-Of-Care Diagnostics
Microfluidics
Qpcr
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Next-Generation Sequencing
Real-Time Pcr (Qpcr)
Isothermal Amplification Methods
Line Probe Assays
Next-Generation Sequencing
Applications and Potential Applications for Molecular Point-Of-Care
Major Testing Applications for Molecular Poc Diagnostics
Reclassification of Ridts
Strep A
Respiratory Syncytial Virus (Rsv)
Emerging Applications
Zika
Other Respiratory Infections
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Other Tropical and Neglected Diseases
Cancer
European Device Regulations Nearing
Chapter 3: Market Analysis
Molecular Point of Care Market Analysis
Molecular Point of Care Market, 2022-2027 ($M, %)
Molecular Point of Care Market, 2022-2026 ($M)
Molecular Point of Care Market Share, by Vendor (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022 ($M, %)
Molecular Point of Care Market Share, by Vendor (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022 (%)
Geographic Breakout of the Molecular Point of Care Market, 2022
Segment Breakout of Molecular Point of Care Market, 2022 (Covid-Respiratory Vs. Other)
Breakout of Molecular Point of Care Market (Respiratory, Other), 2022 (%)
"Near Patient Molecular" Market
Near Patient Molecular Systems Market, 2022-2027
Market Share Near Patient
Market Share, Near Patient Molecular Testing, (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022
Chapter 4: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/bt7reu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.